Signup Crypto ETF Stocks News

KeyCorp Predicts Kaiser Aluminum's Q1 Earnings (NASDAQ:KALU)

KeyCorp analyst S. Mckinney projects Kaiser Aluminum's Q1 2026 EPS to be $1.85, rating the stock "Overweight" with a $170 price target and forecasting robust full-year EPS for 2026 and 2027. Despite a consensus "Hold" rating from other analysts and a lower consensus price target of $126.25, the company trades near its 12-month high and recently declared a quarterly dividend of $0.77. Kaiser Aluminum, which missed its last quarterly EPS estimate by $0.03 but saw revenue rise 21.4% year-over-year, also experienced recent insider selling by its CFO.

Source: MarketBeat
April 20, 2026 | 05:09:49
Category: General

Haemonetics Corp stock (US4041191090): Why mobile-first Discover changes matter more now for medtech

Google's 2026 Discover Core Update, completed in February 2026, is shifting towards proactive, personalized mobile feeds, which significantly impacts how investors receive information about companies like Haemonetics Corp (NYSE:HAE). This update allows for faster access to insights on plasma collection trends, software growth, and hospital demand shifts, providing investors with an informational edge without active searching. The article details how this mobile-first approach amplifies key data points, segment performance, and strategic initiatives for Haemonetics, making complex financial information more accessible and enhancing decision-making for both retail and institutional investors.

Source: AD HOC NEWS
April 20, 2026 | 05:10:28
Category: General

The Sherwin-Williams Co stock (US8243481061): Why mobile-first delivery now matters more for investo

Google's 2026 Discover Core Update is changing how investors receive information on The Sherwin-Williams Co stock (US8243481061) by prioritizing mobile-first, proactive and high-density financial insights directly in their feeds. This update leverages Web and App Activity to deliver tailored stories on market trends, strategic moves, and financial performance, giving investors a quicker edge in tracking opportunities related to Sherwin-Williams. The article details how Sherwin-Williams' business model and various financial aspects, such as pricing power, acquisition strategy, and dividend growth, are well-suited for this mobile-optimized content delivery.

Source: AD HOC NEWS
April 20, 2026 | 05:11:22
Category: General

PepsiCo Inc. stock (US7134481081): Is its snack and beverage dominance still the key to steady investor returns?

This article analyzes PepsiCo Inc.'s stock, highlighting its strong position in the consumer staples sector due to a diversified portfolio of snacks and beverages. It discusses the company's business model, product lineup, market drivers, and competitive advantages, making it an attractive option for investors seeking stability and reliable dividends. The piece also touches on analyst perspectives, potential risks, and investment considerations for PepsiCo shareholders.

Source: AD HOC NEWS
April 20, 2026 | 05:12:17
Category: General

Fresenius Medical Care stock (DE0005785802): Why Google Discover changes matter more now

Google's 2026 Discover Core Update is revolutionizing how retail investors access information, particularly for stocks like Fresenius Medical Care (DE0005785802). This update prioritizes personalized, mobile-first content directly in users' feeds, offering faster access to critical market insights for better decision-making. Investors tracking Fresenius Medical Care can expect proactive delivery of news on dialysis services, kidney care innovations, and financial metrics, giving them a competitive edge in volatile markets.

Source: AD HOC NEWS
April 20, 2026 | 05:13:25
Category: General

KeyCorp Forecasts MasTec's Q3 Earnings (NYSE:MTZ)

KeyCorp has forecasted MasTec's (NYSE:MTZ) Q3 2026 earnings at $2.61 EPS and reiterated an "Overweight" rating with a $335 price target, also projecting FY2026 EPS of $8.04 and FY2027 EPS of $9.20. The company recently exceeded Q4 revenue and EPS estimates and announced FY2026 guidance of $8.40 EPS, with its stock trading near a 52-week high and analyst sentiment largely bullish. Insider sales by two directors have been noted, though institutional ownership remains high.

Source: MarketBeat
April 20, 2026 | 05:13:49
Category: General

Study shows Sanofi's Nuvaxovid better tolerated than Moderna's mNEXSPIKE

A new study presented by Sanofi at the ESCMID Global Congress revealed that its protein-based COVID-19 vaccine, Nuvaxovid, is better tolerated than Moderna's mNEXSPIKE. The COMPARE study, a Phase 4 trial involving 1,000 adults, found that Nuvaxovid resulted in significantly fewer systemic and local side effects, as well as less disruption to daily activities. Sanofi suggests that improved tolerability could enhance vaccine confidence and uptake for annual immunization.

Source: www.marketscreener.com
April 20, 2026 | 05:14:04
Category: General

Q2 Earnings Forecast for Quanta Services Issued By KeyCorp

KeyCorp analyst S. Jain has issued a Q2 2026 EPS forecast of $2.72 for Quanta Services and a FY2026 EPS forecast of $11.87, which is above the MarketBeat consensus but below Quanta's own guidance. Several other firms have also raised their price targets for PWR, contributing to a "Moderate Buy" consensus rating and an average target price of $595.82, with the stock trading near its 52-week high after beating previous earnings estimates. Analysts view Quanta Services positively due to sustained infrastructure spending, its role in the AI data center buildout, and a growing backlog, despite some macro market risks.

Source: MarketBeat
April 20, 2026 | 05:14:21
Category: General

Merck provides grant funding to boost American lung cancer screening rates

Merck & Co Inc. has provided grant funding through the National Comprehensive Cancer Network (NCCN) to four research teams to improve lung cancer screening rates and reduce care gaps. This initiative aims to increase access, lower disparities, and support retention in annual lung cancer screenings, especially given the low national screening rate of about 18% for eligible Americans. The article also highlights other innovations in early lung cancer detection, including AI-powered CT scan analysis and breath tests.

Source: Mugglehead Investment Magazine
April 20, 2026 | 05:16:01
Category: General

S&P Global Inc stock (US78409V1044): Why Google Discover changes matter more now

Google's 2026 Discover Core Update is significantly altering how users access news and insights about S&P Global Inc. stock on mobile devices. This update prioritizes personalized, mobile-first financial content directly in the Google app feed, offering faster, proactive updates on market data, ratings, and indices. The shift aims to provide investors with a competitive edge by delivering timely information on S&P Global's strategic moves and performance without the need for manual searches.

Source: AD HOC NEWS
April 20, 2026 | 05:18:23
Category: General

© Natavest 2025 - 2026